P
ISSUER//CIK 0000882104
PDL BIOPHARMA, INC.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 413.4 KBPROTEIN DESIGN LABS INC/DEAug 17, 12:42 PM ET·0001140361-05-006424
- 428.5 KBPROTEIN DESIGN LABS INC/DEAug 5, 6:26 PM ET·0001140361-05-005779
- 420.1 KBPROTEIN DESIGN LABS INC/DEAug 5, 6:24 PM ET·0001140361-05-005778
- 422.1 KBPROTEIN DESIGN LABS INC/DEAug 5, 6:24 PM ET·0001140361-05-005777
- 418.2 KBPROTEIN DESIGN LABS INC/DEAug 5, 6:23 PM ET·0001140361-05-005776
- 411.2 KBPROTEIN DESIGN LABS INC/DEJul 25, 5:19 PM ET·0001140361-05-005405
- 414.5 KBPROTEIN DESIGN LABS INC/DEJul 12, 5:16 PM ET·0001140361-05-005150
- 4/A22.5 KBPROTEIN DESIGN LABS INC/DEJun 27, 5:45 PM ET·0001104659-05-029918
- 4/A17.9 KBPROTEIN DESIGN LABS INC/DEJun 27, 5:45 PM ET·0001104659-05-029917
- 4/A14.8 KBPROTEIN DESIGN LABS INC/DEJun 27, 5:44 PM ET·0001104659-05-029916
Insiders
10- BACKER MARK PVP, Technical Development
- BENJAMIN WILLIAM RVP, Research & Clinical Tech
- BENNER STEVEN ESVP and Chief Medical Officer
- CALDWELL PATRICK MVP, Finance and Controller
- CHARLSON FRANCES GVP, Human Resources
- DREWS JURGENDirector
- EBERSOLE DOUGLAS OSVP, Legal & Corp Development
- GARCIA RODRIGUEZ SERGIOVP, Legal and General Counsel
- KLINGBELL CORINEVP, Preclinical Development
- MCDADE MARKDirector, CEO
Tickers
No tickers on record
Addresses
business
59 DAMONTE RANCH PARKWAY SUITE B-375
RENO, NV, 89521
mailing
59 DAMONTE RANCH PARKWAY SUITE B-375
RENO, NV, 89521
Former Names
- PROTEIN DESIGN LABS INC/DE2006-01-19